Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Pain Detecting and Analgesic Stimulating Device on Low Back Pain

8 gennaio 2016 aggiornato da: Jo Nijs, Vrije Universiteit Brussel

The Effects of a Pain Detecting and Analgesic Stimulating Device on Low Back Pain Patients' Clinical Outcomes

Purpose of study is to test in a randomized controlled trial (RCT) the effects of the Nervomatrix device on various clinical outcomes of patients with low back pain, as well as its mechanisms of action.

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

This will be a matched randomized-controlled trial - RCT. Using random numbers from a random number generator, pairs of patients will be randomized to either the Nervomatrix stimulation (experimental group) or to sham stimulation (controls). Matching of pairs will be done based on the baseline data of the primary outcomes - pain and disability, as well as on other treatments received.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

39

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Brussel, Belgio, 1050
        • Vrije Universiteit Brussel

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • chronic low back pain persisting for at least 3 months

Exclusion Criteria:

  • patho-anatomical diagnosis (such as fractures, tumors, rheumatic diseases and neurological diseases)
  • initiated a new conventional therapy during the study period
  • pregnant
  • patients having a cardiac pacemaker, implanted defibrillator, or other implanted metallic or electronic device

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Stimulation
Patients will undergo 6 sessions, each including 20 minutes of stimulation. These are given after the Nervomatrix device determines the peak pain regions for each patient, and selects to stimulate the top 10 regions with least skin resistance. The frequency of stimulation is 8Hz, at an intensity matched for each patient's tolerance, without inflicting any pain. The location of the stimulations will change in accordance to the changes in the peak pain regions, reflecting changes in tissue physiology possibly linked to clinical improvements.
The Nervomatrix device first measures skin impedance, and then creates a digital pain matrix map of the back. Regions with low resistance are then selected for brief electric stimulation, thus targeting the treatment to specific peak pain regions. Preliminary evidence supports the effectiveness of this device in reducing pain and disability over 6 sessions
Altri nomi:
  • Nervomatrix
Comparatore fittizio: sham stimulation
Patients will undergo 6 sessions, each including 20 minutesof sham stimulation (no stimulation). These are given after the Nervomatrix device determines the peak pain regions for each patient, and selects to stimulate the top 10 regions with least skin resistance.
The Nervomatrix device first measures skin impedance, and then creates a digital pain matrix map of the back. Regions with low resistance are then selected for brief mechanical pressure.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The change in the amount of steps climbed during one minute
Lasso di tempo: measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
Stair climbing: Participants were asked to climb up and down 5 stairs for 1 minute, using the rail for support if required. The total amount of steps climbed will be recorded
measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The change in central sensitization inventory
Lasso di tempo: measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
Part A of 25 statements related to current health symptoms. Each of these items is measured on a 5-point temporal Likert scale, with the following numeric rating scale: never (0), rarely (1), sometimes (2), often (3), and always (4). A cumulative score ranges from 0 to 100. Additionally information is collected in Part B on previously diagnosed central sensitivity syndromes and related conditions.
measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
The change in Pain Catastrophizing Scale
Lasso di tempo: measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
will be used to assess pain catastrophizing. It consists of 13 items describing different thoughts and feelings that individuals may experience when they are experiencing pain. Items are scored on a 5-point scale, and total scores are counted by adding up all individual items scores. Higher scores correspond to more severe catastrophic thoughts about pain.
measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
The change in revised Illness perception questionnaire
Lasso di tempo: measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
will be used for assessing the patients' illness perceptions, as it is known that patients with maladaptive illness perceptions (e.g. expecting that their back problem will last for a long time, or holding weak beliefs in the controllability of their back problem) are more likely to have poor clinical outcomes 6 months after they consulted their physician
measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
The change in average pain intensity
Lasso di tempo: measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
average pain rating in the last seven days using a 100 mm Visual Analogue Scale (VAS)
measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
The change in Quebec Back Pain Disability Scale
Lasso di tempo: measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
This questionnaire consists of 20 activity related questions which the patient has to score on a six points scale (0= no; 5= not capable to perform the activity). The total score represents a percentage of functional limitations the patient experiences during daily life.
measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
The change in Tampa Scale of Kinesiophobia
Lasso di tempo: measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)
Tampa Scale of Kinesiophobia is a 17-item questionnaire developed to measure the fear of movement and (re)injury. Each item is scored on a four-point Likert scale ranging from "strongly disagree" [1] to "strongly agree" [4]. Ratings are added up to give a total score ranging from 17-68 points, with the higher values reflecting greater fear of (re)injury
measured prior to the first treatment session (baseline) and immediately following the 6th treatment session (after three weeks)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 dicembre 2013

Completamento primario (Effettivo)

1 dicembre 2014

Completamento dello studio (Effettivo)

1 febbraio 2015

Date di iscrizione allo studio

Primo inviato

13 dicembre 2013

Primo inviato che soddisfa i criteri di controllo qualità

2 ottobre 2014

Primo Inserito (Stima)

3 ottobre 2014

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Stima)

12 gennaio 2016

Ultimo aggiornamento inviato che soddisfa i criteri QC

8 gennaio 2016

Ultimo verificato

1 gennaio 2016

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • NeMaLBP

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Stimulation

3
Sottoscrivi